We hereby evaluated the specificity and quality of COVID-19 humoral response by accurately assessing the IgG, IgA, and IgM responses using secondary antibodies that were only directed against the heavy chain of these Igs (gamma, alpha, and mu, respectively)—not the light chains—thus increasing the specificity of our assays. This evidence concerns the gene CD79A and COVID-19.